NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm. (Q38013696)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639106%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639106%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639106%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Ritsuro Suzuki

series ordinal

1

1 reference

27 August 2017

publication date

1 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639106%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

published in

Current Oncology Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639106%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639106%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639106%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

395-402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22639106%20AND%20SRC:MED&resulttype=core&format=json

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Extranodal NK/T-cell lymphoma: diagnosis and treatment cues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Treatment of localized extranodal NK/T cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Identification of a common T/natural killer cell progenitor in human fetal thymus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

PRDM1 is a tumor suppressor gene in natural killer cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0245-9

Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage

21 January 2018

1 reference

12 December 2020

Biology and clinical relevance of human natural killer cells

1 reference

12 December 2020

Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment

1 reference

12 December 2020

Characteristics and uses of natural killer cells

1 reference

12 December 2020

Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma

1 reference

12 December 2020

Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients

1 reference

12 December 2020

Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.

1 reference

12 December 2020

Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas

1 reference

12 December 2020

P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833.

1 reference

12 December 2020

Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology

1 reference

12 December 2020

Expression of adult and fetal natural killer cell markers in sinonasal lymphomas

1 reference

12 December 2020

Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis.

1 reference

12 December 2020

Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma

1 reference

12 December 2020

Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells

1 reference

12 December 2020

Nasal T-cell lymphoma as a type of so-called "lethal midline granuloma"

1 reference

12 December 2020

Epstein-Barr virus--associated diseases in humans

1 reference

12 December 2020

Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity

1 reference

12 December 2020

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type

1 reference

12 December 2020

Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells

1 reference

12 December 2020

Differences between nasal and extranasal NK/T-cell lymphoma

1 reference

12 December 2020

Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia

1 reference

12 December 2020

CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas

1 reference

12 December 2020

Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy

1 reference

12 December 2020

Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients

1 reference

12 December 2020